Publications by authors named "Abdulrazzak Charbaji"
Purpose: To ascertain the anatomic factors that help achieve non-surgical sealing in full thickness macular hole (FTMH).
Methods: Retrospective collaborative study of FTMH that closed without surgical intervention.
Results: A total of 78 patients (mean age 57.
Aim: To assess the 30-month outcome of treat and extend (TAE) intravitreal ziv-aflibercept therapy in eyes with macular diseases.
Methods: In this prospective study, consecutive subjects received intravitreal 0.05 mL ziv-aflibercept (1.
Purpose: There is no established therapy for exudative-hemorrhagic complications in primary retinal arteriolar macroaneurysm (RAM).
Methods: Retrospective multicenter interventional study of anti-vascular endothelial growth factor in symptomatic RAMs. Central macular thickness in μm and best-corrected visual acuity in logMar were correlated with the RAM size and distance to the macula.
Aim: To assess the two-year outcome of intravitreal ziv-aflibercept (IVZ) in eyes with macular diseases.
Methods: Consecutive subjects with various macular diseases that received six or more of 0.05 mL IVZ (1.
Aims: To investigate the long-term safety of intravitreal ziv-aflibercept in eyes receiving six or more intravitreal injections of ziv-aflibercept, an off-label substitute to the approved aflibercept.
Methods: Consecutive patients with retinal disease receiving six or more of intravitreal 0.05 mL ziv-aflibercept (1.
Purpose: Paraproteinemia relates to monoclonal gammopathy-producing pathologic antibodies with serous macular detachment being an uncommon ocular manifestation. We ascertained the clinical course of maculopathy in paraproteinemia and investigated the effect of various therapeutic methods on the resolution of subretinal deposits.
Design: Multicenter, retrospective, observational case series.